Ysios news
16.07.19
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury
26.06.19
Sanifit announces €72.2M ($80.9M) financing in Spain’s largest private biotech fundraise
portfolio news
09.10.19
Minoryx Therapeutics completes enrollment in FRAMES phase 2 trial with leriglitazone in Friedreich’s Ataxia
01.10.19
AM-Pharma Expands its Senior Team in Preparation for a Pivotal Phase III Trial of recAP in Acute Kidney Injury
